跳至主要内容
临床试验/NCT00702026
NCT00702026已完成不适用

The Effect of a Multispecies Probiotic on Hypersensitivity in IBS Patients

Maastricht University Medical Center1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2008年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Pain tolerance threshold

研究概览

简要总结

The purpose of this study is to determine whether a specifically designed multispecies probiotic decreases visceral hypersensitivity in IBS-patient (defined by an increased pain tolerance threshold). Moreover, the effect on general symptom scores and inflammatory and microbiological parameters will be studied.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Clinical diagnosis of IBS according to the Rome III criteria
  • •Increased visceral perception according to barostat measurements, defined as a pain tolerance threshold at smaller than or equal to 23 mmHg
  • •Age between 18 and 65 years
  • •BMI between 18.5 and 30 kg/m2

排除标准

  • •Known gastro-intestinal diseases
  • •Major abdominal surgery
  • •Previous radiotherapy, chemotherapy
  • •Clinical significant systemic diseases
  • •Critically ill patients or patients suffering from severe acute pancreatitis
  • •Patients with organs failure
  • •Patients receiving enteral feeding
  • •Excessive alcohol intake (greater than 15 consumptions per week)
  • •(planned) pregnancy or lactation
  • •Use of pre-, probiotics in the month before and during the study
  • •Use of antibiotics in the two months before and during the study
  • •Use of anti-diarrhoea medication, anti-laxatives or anti-acid medication in the two weeks before and during the study
  • •Use of anti depressives (especially SSRI's) in the month before and during the study
  • •Use of other medication if less then one month on stable dosage

研究组 & 干预措施

1

Experimental

干预措施: multispecies probiotic (Ecologic 801) (Dietary Supplement)

2

Placebo Comparator

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Pain tolerance threshold

时间窗: t=0 and t=6 weeks

VAS score for pain at pressure step 29 mmHg

时间窗: t=0 and t=6 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Effect of a Multispecies Probiotic on... | 临床试验